NCT04518020

Brief Summary

Implant placement in the posterior part of the maxilla is frequently compromised due to atrophy of the alveolar process. Therefore, alveolar ridge augmentation is frequently necessary before or in conjunction with implant placement. The most commonly used method to augment the maxillary premolar and molar region involves the maxillary sinus floor augmentation (MSFA) with autogenous bone graft or a bone substitute. However, the use of autogenous bone grafts is associated with risk at the donor site morbidity and unpredictable graft resorption. Consequently, short implants are used increasingly to eliminate the need for bone augmentation. However, long-term studies comparing short implants and standard implants in conjunction with MSFA supporting single crown restoration in the posterior maxilla are missing. The primary outcome measures include survival of implant and suprastructures, peri-implant marginal bone level (MBL), professional evaluation of the suprastructure and soft tissue using pink esthetic score (PES) and white esthetic score (WES), patient satisfaction using visual analogue scale (VAS), and oral health related quality of life using oral health impact profile (OHIP-14) questionnaire. Secondary outcome measure include evaluation of the complication rate related to the two treatment modalities.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2016

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 16, 2016

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 19, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

4.6 years

First QC Date

August 12, 2020

Last Update Submit

July 19, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Survival of suprastructures.

    Survival of suprastructures is defined as absence of mechanical/or biological complications causing loss of suprastructures. Chipping of ceramics and loosening of the suprastructure were not categorized as loss of suprastructure.

    1-year follow up

  • Survival of implants.

    Survival of implants is defined as clinically stable and osseointegrated implants with absence of mobility, progressive marginal bone loss, and infection.

    1-year follow up

  • Radiographic MBL.

    Measurement of marginal bone level in millimeter.

    1-year follow up

  • Professional evaluation of the prosthetic restoration and soft tissue using pink esthetic score (PES) and white esthetic score (WES).

    Esthetic evaluation of suprastructure and soft tissue using PES and WES. PES includes 7 different variables: mesial papilla, distal papilla, soft-tissue level, soft-tissue contour, alveolar process deficiency, soft-tissue colour, and texture. Each variable is assessed with a 0, 1, or 2 score, with 0 being the poorest score and 2 the best according to the degree of match or mismatch compared with the anterior premolar or molar. The highest possible PES is 14. WES includes 5 different variables: Crown form, volume, colour, translucency, and texture. Each variable is assessed with a 0, 1, or 2 score, with 0 being the poorest score and 2 the best according to the degree of match or mismatch compared with the anterior premolar or molar. The highest possible WES is 10.

    1-year follow up

  • Patient satisfaction.

    Evaluation of patient satisfaction using visual analogue scale (VAS). VAS with 0 indicating extreme dissatisfaction and 10 indicating complete satisfaction.

    1-year follow up

  • Oral health related quality of life as defined by oral health impact profile (OHIP-14).

    Evaluation of oral health related quality of life using OHIP-14 questionnaire. OHIP-14 scale ranges from 0 to 56, with higher scores indicating poorer oral health impact profile.

    1-year follow up

Secondary Outcomes (1)

  • Complications.

    1-year follow up

Study Arms (2)

Short implant

ACTIVE COMPARATOR

Short implant 6 mm installed

Procedure: 40 patients will be randomly allocated to short implants and standard implants in conjunction with MSFA

Conventional implant + bone augmentation

OTHER

Standard length implant 13 mm in conjunction with maxillary sinus floor augmentation serves as a control group

Procedure: 40 patients will be randomly allocated to short implants and standard implants in conjunction with MSFA

Interventions

40 patients will be randomly allocated to short implants (group 1) and standard implants in conjunction with MSFA using 50% particulated autogenous mandibular bone graft mixed with 50% Bio-Oss (group 2).

Conventional implant + bone augmentationShort implant

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>20 years
  • Partial edentulism in the posterior maxilla.
  • Height and weight of the maxillary alveolar process of at least 5.5 mm.
  • Mandibular occluding teeth.

You may not qualify if:

  • General contraindications to implant therapy.
  • Poor oral hygiene.
  • Progressive periodontitis.
  • Acute infection in the area intended for implant placement.
  • Parafunction, bruxism, or clenching.
  • Psychiatric problems or unrealistic expectations.
  • Heavy tobacco use, define as \>10 cigarettes per day.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Nielsen HB, Schou S, Bruun NH, Starch-Jensen T. Single-crown restorations supported by short implants (6 mm) compared with standard-length implants (13 mm) in conjunction with maxillary sinus floor augmentation: a randomized, controlled clinical trial. Int J Implant Dent. 2021 Jul 16;7(1):66. doi: 10.1186/s40729-021-00348-5.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled clinical trial (RCT)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, PhD. Student, Department of Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 19, 2020

Study Start

November 16, 2016

Primary Completion

July 1, 2021

Study Completion

July 1, 2025

Last Updated

July 20, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share